DataMeds AI (MEDS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on DataMeds AI (MEDS) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +1.00 of bullish evidence against -0.51 bearish.

DataMeds AI last closed at $3.35, -8.97% on the session.

Against the IVW growth benchmark the position is -9.89% over the forecast window.

The read is built from 13 underlying insights — 1 bullish and 12 bearish.

Agreement across those insights is 92%.

16 graded predictions for MEDS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks DataMeds AI in the 99th percentile on return on equity, where 100 is best.

DataMeds AI is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $11.77M.

StockMap tracks DataMeds AI as the 71st largest of the 72 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 48 Neutral, 23 Moderate Underperform and 1 Moderate Outperform.

On that composite DataMeds AI ranks 71st of 72 in the group, against a group median of -0.13.